Therapeutic Asset Ratings

5,099 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Gm-Csf Glioblastoma	University of Florida	P3	B (61)
hb0025 Non-Small Cell Lung Carcinoma	Shanghai Huaota Biopharmaceutical Co., Ltd.	P3	B (61)
hlx17 Non-Small Cell Lung Carcinoma	Shanghai Henlius Biotech	P3	B (61)
Hmpl-760 Relapsed/Refractory Diffuse Large B-Cell Lymphoma	Hutchmed	P3	B (61)
hs-20094 Obesity Disorder	Jiangsu Hansoh Pharmaceutical Co., Ltd.	P3	B (61)
hsk31679 Metabolic Dysfunction-Associated Steatohepatitis	Haisco Pharmaceutical Group Co., Ltd.	P3	B (61)
Hydrocortisone Acute Undifferentiated Leukemia	Therapeutic Advances in Childhood Leukemia Consortium	P3	B (61)
Hydrocortisone Childhood Myelodysplastic Syndrome	Children's Oncology Group	P3	B (61)
Hydrocortisone Prostate Cancer	National Cancer Institute (NCI)	P3	B (61)
Hydrocortisone T-Cell Acute Lymphoblastic Leukemia	Children's Oncology Group	P3	B (61)
ibi310 Hepatocellular Carcinoma	Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.	P3	B (61)
Ibrutinib Follicular Lymphoma	Yazeed Sawalha	P3	B (61)
Ibrutinib Indolent B-Cell Non-Hodgkin Lymphoma	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University	P3	B (61)
Ibuprofen Headache Disorder	Humanis Saglık Anonim Sirketi	P3	B (61)
Immunoglobulin G1, Anti-(Human Cytotoxic T-Lymphocyte-Associated Antigen 4) (Human-Mus Musculus Monoclonal M3 .Gamma.1-Chain), Disulfide With Human-Mus Musculus Monoclonal M3 .Kappa.-Chain, Dimer Renal Cell Carcinoma	Merck Sharp & Dohme LLC	P3	B (61)
Immunoglobulin G1, Anti-(Human Epidermal Growth Factor Receptor) (Human-Mus Musculus Monoclonal Jmt101 ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Jmt101 ?-Chain, Dimer Colorectal Cancer	Shanghai JMT-Bio Inc.	P3	B (61)
Immunoglobulin G1, Anti-(Humanized Mouse Monoclonal Hr3 .Beta.1 Chain Anti-Human Epidermal Growth Factor Receptor), Disulfide With Humanized Mouse Monoclonal Hr3 .Kappa.-Chain, Dimer Pancreatic Neoplasm	Tianjin Medical University Cancer Institute and Hospital	P3	B (61)
Immunoglobulin G1, Anti-(Human Vascular Endothelial Growth Factor Receptor Type Vegfr-2 Extracellular Domain) (Human Monoclonal Imc-1121B .Gamma.-Chain), Disulphide With Human Monoclonal Imc-1121B .Kappa.-Chain, Dimer Colorectal Cancer	Taiho Pharmaceutical Co., Ltd.	P3	B (61)
Immunoglobulin G1, Anti-(Human Vascular Endothelial Growth Factor Receptor Type Vegfr-2 Extracellular Domain) (Human Monoclonal Imc-1121B .Gamma.-Chain), Disulphide With Human Monoclonal Imc-1121B .Kappa.-Chain, Dimer Non-Small Cell Lung Carcinoma	University of Chicago	P3	B (61)
Immunoglobulin G2, Anti-(Human Ctla-4 (Antigen)) (Human Monoclonal Cp-675206 Clone 11.2.1 Heavy Chain) Disulphide With Human Monoclonal Cp-675206 Clone 11.2.1 Light Chain, Dimer Small Cell Lung Carcinoma	Alliance Foundation Trials, LLC.	P3	B (61)
Inavolisib Breast Cancer	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	P3	B (61)
Indocyanine Green Breast Cancer	Isabelle Henskens	P3	B (61)
Ipatasertib Breast Cancer	German Cancer Research Center	P3	B (61)
Ipilimumab Prostate Cancer	Australian and New Zealand Urogenital and Prostate Cancer Trials Group	P3	B (61)
Irinotecan Urinary Bladder Carcinoma	Toray Industries, Inc	P3	B (61)

Showing 2076 to 2100 of 5,099 assets

PreviousPage 84 of 204Next